InvestorsHub Logo
Followers 45
Posts 1686
Boards Moderated 0
Alias Born 11/28/2018

Re: None

Thursday, 07/30/2020 9:27:08 PM

Thursday, July 30, 2020 9:27:08 PM

Post# of 233207
Yes as my prior post yesterday nailed it. Three weeks to uplist. No results til end of next week which is extended to hopefully only 10 days. No S/C analysis til end of August. Not enough patients to meet 50% at 195. EAU not until September at earliest. M2M probably extended for phase 3 trial. Delay delay delay BP don’t want this gem to be realized. Offers will come in once M2M results announced. Then big guessing game as to which one of BP really wants Leronlimab in its pipeline and how much are they willing to pay. IMO of course
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News